In July 2023, their Fibroid Mapping Reviewer Application (FMRA) received 510(k) clearance from the U.S. FDA.
In Oct 2023, they successfully closed a Pre-Series A funding round led by KITVEN Fund 3 Biotech, with participation from Malpani Ventures, SucSEED Indovation Fund, and high-net-worth individuals such as Dr. Dinesh Patel and Ganesh Subramaniam.

Founded in 2016, its a Bengaluru-based medical device startup focused on developing minimally invasive solutions for women’s health, particularly the treatment of uterine fibroids. Their flagship product, GYIDE, is a novel, uterus-preserving technology aimed at providing a scarless alternative to traditional treatments. The company has approximately 50 employees.

• In July 2024, received a manufacturing license from the Central Drugs Standard Control Organization (CDSCO) for its flagship product, GYIDE
• Selected as one of the top seven startups for the OB/GYN Innovation Award by Femtech World